ISPE Invited to Participate in DAF ACT Initiative to Support Domestic Manufacturing of Active Pharmaceutical Ingredients
ISPE Invited to Participate in DAF ACT Initiative to Support Domestic Manufacturing of Active Pharmaceutical Ingredients Share Article ISPE announced their participation in the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) to advise Regulatory, Technical, and Workforce elements favorable to creating a more robust and sustainable domestic pharmaceutical manufacturing base for Active Pharmaceutical Ingredients (APIs). This partnership aligns with ISPE’s mission to support the international pharmaceutical industry and multiple programs we actively lead, including the Dr...